NO931888L - Cyclopeptider og anvendelser derav p} slimhinner - Google Patents

Cyclopeptider og anvendelser derav p} slimhinner

Info

Publication number
NO931888L
NO931888L NO931888A NO931888A NO931888L NO 931888 L NO931888 L NO 931888L NO 931888 A NO931888 A NO 931888A NO 931888 A NO931888 A NO 931888A NO 931888 L NO931888 L NO 931888L
Authority
NO
Norway
Prior art keywords
formula
basic
amino acid
well
tolerable salts
Prior art date
Application number
NO931888A
Other languages
English (en)
Norwegian (no)
Other versions
NO931888D0 (no
Inventor
Juergen Dr Sandow
Walter Dr Duerckheimer
Guenter Dr Ditzinger
Hans-Peter Prof Merkle
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of NO931888D0 publication Critical patent/NO931888D0/no
Publication of NO931888L publication Critical patent/NO931888L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/52—Cyclic peptides containing at least one abnormal peptide link with only normal peptide links in the ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62—Polymyxins; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO931888A 1992-05-26 1993-05-25 Cyclopeptider og anvendelser derav p} slimhinner NO931888L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4217350 1992-05-26

Publications (2)

Publication Number Publication Date
NO931888D0 NO931888D0 (no) 1993-05-25
NO931888L true NO931888L (no) 1993-11-29

Family

ID=6459729

Family Applications (1)

Application Number Title Priority Date Filing Date
NO931888A NO931888L (no) 1992-05-26 1993-05-25 Cyclopeptider og anvendelser derav p} slimhinner

Country Status (18)

Country Link
US (1) US5565423A (OSRAM)
EP (1) EP0571921B1 (OSRAM)
JP (1) JPH0672899A (OSRAM)
KR (1) KR940005669A (OSRAM)
AT (1) ATE144991T1 (OSRAM)
AU (1) AU665676B2 (OSRAM)
CA (1) CA2096889A1 (OSRAM)
DE (1) DE59304389D1 (OSRAM)
DK (1) DK0571921T3 (OSRAM)
ES (1) ES2096140T3 (OSRAM)
FI (1) FI932351A7 (OSRAM)
GR (1) GR3021570T3 (OSRAM)
HU (1) HUT64776A (OSRAM)
IL (1) IL105795A (OSRAM)
NO (1) NO931888L (OSRAM)
NZ (1) NZ247680A (OSRAM)
TW (1) TW274552B (OSRAM)
ZA (1) ZA933629B (OSRAM)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
EP1487474A4 (en) * 2002-02-25 2006-11-29 Chiron Corp INTRANASAL ADMINISTRATION OF MC4-R AGONISTS
US6803046B2 (en) * 2002-08-16 2004-10-12 Bracco International B.V. Sincalide formulations
WO2004084859A2 (en) * 2003-03-21 2004-10-07 Nastech Pharmaceutical Company Inc. Nasal calcitonin formulations containing chlorobutanol
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
US20080261933A1 (en) * 2007-04-23 2008-10-23 Jens Hoffmann Combination of progesterone-receptor antagonist together with a lutein-hormone-releasing hormone agonist and antagonist for use in brca mediated diseases
US8343912B2 (en) 2008-12-23 2013-01-01 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
BR112014012016A2 (pt) 2011-11-18 2017-05-16 Cantab Anti-Infectives Ltd compostos
BR112015029309A2 (pt) 2013-05-22 2017-07-25 New Pharma Licence Holdings Ltd derivados de polimixina e seu uso em terapia de combinação junto com antibióticos diferentes
WO2016083531A1 (en) 2014-11-26 2016-06-02 New Pharma Licence Holdings Limited Compounds
FI126143B (en) * 2015-01-15 2016-07-15 Northern Antibiotics Oy Polymyxine derivative and its uses
US11110063B2 (en) 2017-08-25 2021-09-07 MAIA Pharmaceuticals, Inc. Storage stable sincalide formulations
US11459357B2 (en) 2018-06-25 2022-10-04 Spero Therapeutics, Inc. Polymyxin compounds
US20220226479A1 (en) * 2019-03-25 2022-07-21 University Of Tsukuba Cell layer permeation promoter. composition for facilitating drug absorption. and pharmaceutical composition
CN116332993A (zh) * 2023-03-13 2023-06-27 遵义医科大学 一种氨基噻唑肟酰胺类化合物及其制备方法和应用
CN117649950B (zh) * 2024-01-29 2024-05-17 北京大学第三医院（北京大学第三临床医学院） 一种催产素药物作用动力学模型及其构建方法和应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2124060B1 (OSRAM) * 1971-02-02 1974-04-12 Rhone Poulenc Sa
WO1988000950A2 (en) * 1986-08-06 1988-02-11 Fauchere Jean Luc Production of covalent-linked conjugates from an antibiotic and a non-toxic derivative of polymyxine b
DE3726324A1 (de) * 1987-08-07 1989-02-16 Hoechst Ag Cyclopeptide als resorptionsfoerderer bei applikation auf die schleimhaeute
US5177059A (en) * 1989-11-15 1993-01-05 Sandoz Ltd. Polymyxin B conjugates

Also Published As

Publication number Publication date
HU9301520D0 (en) 1993-09-28
AU665676B2 (en) 1996-01-11
FI932351A0 (fi) 1993-05-24
HUT64776A (en) 1994-02-28
ZA933629B (en) 1993-12-20
CA2096889A1 (en) 1993-11-27
DE59304389D1 (de) 1996-12-12
JPH0672899A (ja) 1994-03-15
NZ247680A (en) 1995-07-26
ATE144991T1 (de) 1996-11-15
NO931888D0 (no) 1993-05-25
EP0571921A2 (de) 1993-12-01
EP0571921A3 (OSRAM) 1994-01-12
EP0571921B1 (de) 1996-11-06
FI932351A7 (fi) 1993-11-27
IL105795A (en) 1998-03-10
US5565423A (en) 1996-10-15
AU3876693A (en) 1993-12-02
TW274552B (OSRAM) 1996-04-21
IL105795A0 (en) 1993-09-22
DK0571921T3 (da) 1997-04-01
GR3021570T3 (en) 1997-02-28
ES2096140T3 (es) 1997-03-01
KR940005669A (ko) 1994-03-22

Similar Documents

Publication Publication Date Title
NO931888L (no) Cyclopeptider og anvendelser derav p} slimhinner
AU7535798A (en) Novel cyclosporin derivatives, preparation and pharmaceutical compositions containing same
NO891082D0 (no) Fremgangsmaate for fremstilling av peptidforbindelser.
ZA9711606B (en) Cyclosporin derivatives, their preparation and the pharmaceutical compositions which contain them.
TW343198B (en) Cyclopeptides useful as adhesion inhibitors, process for the preparation thereof, and pharmaceutical composition containing them
AU5669398A (en) Novel cyclosporin derivatives, method of preparation and pharmaceutical compositions containing them
EP0922454A3 (en) Arginine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
NO2005020I2 (no) Caspofungin, eventuelt i form av et farmasoeytisk akseptabelt salt saerlig caspofungiacetat
AU4869690A (en) Pyrazolopyridine compound and processes for preparation thereof
MD1233B1 (en) Erythromycin derivatives, process for their preparation and pharmaceutical composition on base thereof
EP0781781A3 (en) Camptothecin derivatives
AU5669198A (en) Cyclosporin derivative, its preparation and pharmaceutical compositions containing same
AU2983889A (en) 3-alkenyl-1-azabicyclo {3.2.0} hept-2-ene-2-carboxylic acid compounds
TR199802534T2 (xx) Leptin (OB Protein) fragmanlar�
NO911041L (no) Fremgangsmaate for fremstilling av 3-tetrazolyltiometyl-cefalosporinantibiotika.
CA2040086A1 (en) Novel 2,9-disubstituted-4h-pyrido[1,2-a]pyrimidin-4-ones
DK0548794T3 (da) Polyaspartamidderivater som adsorptionsmidler for galdesyrer, polyaspartamidderivater ladet med galdesyrer, fremgangsmåder
IT1244501B (it) Derivati amminoacilici e oligopeptidici dell'allopurinolo dotati di attivita' immunostimolante e composizioni farmaceutiche che li contengono
IL90552A0 (en) Condensed pyrazole 3-oxo-propanenitrile derivatives,their preparation and pharmaceutical compositions containing them
MY110004A (en) Biologically active ureido derivatives useful as antimetastatic agents.
CA2179634A1 (en) 4-arylisoindole analgesics
ATE229028T1 (de) 9-n-ethenylderivate von 9(s)-erythromycylamin
EP0613375A4 (en) PHARMACEUTICAL LYSINE CONTAINING POLYPEPTIDE COMPOSITIONS AND METHOD FOR USE THEREOF.
NO934791L (no) Cefalosporinsalter og fremgangsmåte for fremstilling derav
IE781545L (en) Benzimidazole-2-derivatives.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application